Stock Events

Stock Events

Organon 

$13.78
645
+$0.01+0.07% 19:59 Today
+$0.00+0%20:10After hours

Statistics

Day High
13.78
Day Low
13.76
52W High
13.79
52W Low
5.69
Volume
4,872,466
Avg. Volume
2,714,576
Mkt Cap
3.62B
P/E Ratio
14.54
Dividend Yield
0.58%
Dividend
0.08

Upcoming

Dividends

0.58%Dividend Yield
Sep 26
$0.02
Jun 26
$0.02
Mar 26
$0.02
Dec 25
$0.02
Sep 25
$0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
-58.51%
1Y Growth
-90.7%

Earnings

29OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
0.63
0.76
0.89
1.02
Expected EPS
0.88
Actual EPS
N/A

Financials

3.01%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
6.22BRevenue
187MNet Income

Analyst Ratings

14.00Average Price Target
The highest estimate is 14.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OGN. It's not an investment recommendation.
Merck
133
MRK
Pfizer
120
PFE
AT&T
112
T
Realty Income
108
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical company that competes with Organon in the areas of women's health and biosimilars, making it a direct competitor.
Merck
MRK
Mkt Cap366B
Merck, the former parent company of Organon, competes in the pharmaceutical sector, including women's health and vaccine products.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie competes with Organon in the pharmaceuticals sector, particularly in women's health, with a focus on therapies and treatments.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson is a diversified healthcare giant that competes across various segments, including pharmaceuticals relevant to Organon's market.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biopharmaceutical company that competes with Organon in the biosimilars market, offering alternative products.
Novo Nordisk
NVO
Mkt Cap201.64B
Novo Nordisk is a global healthcare company that, through its biopharmaceutical products, competes with Organon in areas like hormone replacement therapies.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing with Organon in the generics and women's health market.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Organon in developing and commercializing prescription pharmaceuticals.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline is a global healthcare company that competes with Organon in pharmaceuticals and vaccines, including areas of women's health.
Sanofi
SNY
Mkt Cap107.39B
Sanofi is a global biopharmaceutical company focusing on human health, competing with Organon in healthcare solutions, including women's health.

About

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Show more...
CEO
Joseph T. Morrissey Jr.
Employees
10000
Country
United States
ISIN
US68622V1061
WKN
000A3CPKP

Listings

STU
DE
7XP.STU
MI
IT
1OGN.MI
LSE
GB
0A9W.LSE
MU
DE
7XP.MU

0 Comments

Share your thoughts

FAQ

What is Organon stock price today?▼
The current price of OGN is $13.78 USD — it has increased by +0.07% in the past 24 hours. Watch Organon stock price performance more closely on the chart.
What is Organon stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Organon stocks are traded under the ticker OGN.
Is Organon stock price growing?▼
OGN stock has risen by +0.15% compared to the previous week, the month change is a +1.62% rise, over the last year Organon has showed a +42.36% increase.
What is Organon market cap?▼
Today Organon has the market capitalization of 3.62B
When is the next Organon earnings date?▼
Organon is going to release the next earnings report on October 29, 2026.
What were Organon earnings last quarter?▼
OGN earnings for the last quarter are 0.85 USD per share, whereas the estimation was 0.91 USD resulting in a -6.59% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Organon revenue for the last year?▼
Organon revenue for the last year amounts to 6.22B USD.
What is Organon net income for the last year?▼
OGN net income for the last year is 187M USD.
Does Organon pay dividends?▼
Yes, OGN dividends are paid quarterly. The last dividend per share was 0.02 USD. As of today, Dividend Yield (FWD)% is 0.58%.
How many employees does Organon have?▼
As of September 04, 2026, the company has 10,000 employees.
In which sector is Organon located?▼
Organon operates in the Health & Wellness sector.
When did Organon complete a stock split?▼
Organon has not had any recent stock splits.
Where is Organon headquartered?▼
Organon is headquartered in JERSEY CITY, United States.